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Abstract
In this report we describe the relationships between daytime sleepiness, nighttime sleep quality,
stressful life events, and HIV-related fatigue in a sample of 128 individuals; we are reporting the
baseline results of a longitudinal observational study. We examined sleep using the Pittsburg Sleep
Quality Index (PSQI) (a measure of the quality of nighttime sleep), and the Epworth Sleepiness Scale
(ESS), (a measure of daytime sleepiness). Recent stressful life events were measured via a
methodology developed in a previous 9-year HIV study. Poor nighttime sleep was significantly
correlated with fatigue intensity (r = 0.46, p < 0.05), as was daytime sleepiness (r = 0.20, p < 0.05).
However, in multiple regression models, the association between stress and fatigue intensity was not
explained by daytime sleepiness and was only partially explained by nighttime sleep quality. Further
research is needed to better elucidate these relationships.
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Clinical Considerations
The following may help to improve overall quality of sleep in HIV-infected patients:
• Encourage patients to keep a sleep diary to try to determine what factors are associated with poor sleep.
• Educate patients about good sleep hygiene techniques including: use the bed for sleep or sex only, turn off the television and
other sources of sound when trying to sleep, maintain the bedroom at a comfortable temperature.
• Initiate a medication and dietary review with patients:
– Are they taking SSRIs? When?
– Are they taking efavirenz?
– Are they drinking caffeinated beverages after 6 p.m.?
– Are they snacking late in the evening?
– Are they using recreational drugs or drinking excessively?
• Assess for symptoms of sleep apnea.
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The most frequent and debilitating complaint of HIV-infected people is fatigue, defined as
“awareness of a decreased capacity for physical and/or mental activity due to an imbalance in
the availability, utilization, and/or restoration of resources needed to perform
activity” (Aaronson et al., 1999, p. 46). Justice, Rabeneck, Hays, Wu, and Bozzette (1999)
found fatigue to be the most common symptom among people with HIV infection; fatigue was
associated with functional limitation, and greater fatigue predicted lower chances of survival.
Prior to the development of interventions to ameliorate HIV-related fatigue, we need to know
what factors are associated with it, and how these factors are related to one another. Some
researchers have speculated that HIV-related fatigue was a result of physiological factors such
as CD4 count and HIV viral load (e.g., Henderson, Safa, Easterbrook, & Hotopf, 2005;
Simmonds, Novy, & Sandoval, 2005), while others have argued that it was a function of
psychosocial variables such as depression (e.g, Barroso, Carlson, & Meynell, 2003; Voss,
2005). Sleep quality is unique in that poor sleep may have a physiological basis, a psychosocial
basis, or a combination of the two.
The first purpose of this article is to examine the relationships among HIV-related fatigue, poor
nighttime sleep, and daytime sleepiness. Another relationship of interest is whether sleep
quality mediates the stress/fatigue relationship; we have previously reported that stressful life
events were strong predictors of HIV-related fatigue intensity and impairment of functioning
in this sample (Leserman, Barroso, Pence, Salahuddin, & Harmon, in press). Therefore, the
second purpose of this report is to investigate whether the relationship between stress and
fatigue is mediated by sleep quality.
HIV-infected individuals often suffer from poor sleep quality, which may contribute to fatigue
(e.g., Davis, 2004; Phillips, Mock, Bopp, Dudgeon, & Hand, 2006; Rubinstein & Selwyn,
1998). In a systematic review of 29 studies on insomnia in HIV infection, insomnia was
reported frequently and at all stages of HIV infection (Reid & Dwyer, 2005). Darko,
McCutchan, Kripke, Gillin, and Golshan (1992) found that HIV-infected patients were
significantly more likely than non-infected persons to feel fatigued; HIV-infected patients slept
more, napped more, and had diminished midmorning alertness, possibly due to poor nighttime
sleep. Robbins, Phillips, Dudgeon, and Hand (2004) found that, among other factors, fatigue
was significantly related to sleep quality, and Phillips et al. (2004) found that sleep quality
predicted fatigue in HIV-infected subjects. These two reports provided evidence of how closely
poor sleep quality and fatigue are related.
Psychosocial factors, such as not having a place to sleep, having to share a bed with too many
people, or living in an area in which optimal sleep conditions cannot be achieved (e.g., too hot,
too cold, too noisy), can contribute to poor sleep quality as well. Phillips et al. (2004) reported
that perceived stress was associated with HIV-related fatigue. However, no studies have
examined the impact of stressful life events on HIV-related fatigue, although stressful life
events have been associated with fatigue in other diseases (Mancuso, Rincon, Sayles, & Paget,
2005; Van, Egle, & Luyten, 2005). Further examination is needed to determine factors that
might mediate the relationship between HIV-related fatigue and poor sleep, and whether sleep
quality mediates the stress/fatigue relationship. Here, we report baseline data investigating the
cross-sectional relationships between nighttime sleep quality, daytime sleepiness, stressful life
events, and HIV-related fatigue, in a sample of 128 HIV-infected individuals who are being
followed in a longitudinal observational study.
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Any HIV-infected individual 21 years of age and older who could read and speak English and
was mentally competent to provide reliable data (as determined via telephone interview with
the principal investigator) was considered eligible for the study. Between March 2005 and May
2006, 128 fatigued and non-fatigued persons were enrolled in the study. Persons with a co-
morbid condition marked by fatigue such as renal disease, cancer, or multiple sclerosis were
excluded, as were pregnant women and those women less than 12 months postpartum. Flyers
advertising the study were distributed at several HIV treatment centers that typically cared for
a referral population and at the offices of an AIDS service organization in a southern state.
While fatigue was prominent on the flyer, it was clear that we were searching for both fatigued
and non-fatigued people. The institutional review board at a major academic medical center
approved the study protocol, and written informed consent was obtained from each participant;
each was given a copy of the signed consent form.
Procedures
Persons interested in participating in the study contacted the principal investigator who
conducted the preliminary screenings by telephone. Potential participants were then contacted
by one of the two study coordinators and an initial visit was scheduled. Study visits were
conducted at the General Clinical Research Center (GCRC) of an academic medical center.
Participants were encouraged to take breaks whenever they became tired.
Measures
Baseline demographic data were collected at the first study visit by one of two research
assistants during face-to-face interviews with study subjects. An investigator-developed form
was used to collect demographic data including age, sex, race/ethnicity, employment status,
income, medications (including antiretrovirals, antidepressants, and anxiolytics), and HIV-
related illnesses, categorized into B or C illnesses using the Centers for Disease Control and
Prevention guidelines (Centers for Disease Control and Prevention [CDC], 1992).
The HIV-Related Fatigue Scale (HRFS) (Barroso & Lynn, 2002) was used to measure several
aspects of fatigue. The HRFS is a Likert-type self-report measure with the following scales,
each ranging from 1-10: fatigue intensity (8 items, Cronbach's alpha 0.93) and impact of fatigue
on daily functioning (22 items, Cronbach's alpha 0.98), with the latter being divided into three
subscales: impact of fatigue on activities of daily living (ADL) (12 items, Cronbach's alpha
0.96); impact of fatigue on socialization (6 items, Cronbach's alpha 0.93); and impact of fatigue
on mental functioning (4 items, Cronbach's alpha 0.93) (Pence, Barroso, Leserman, Harmon,
& Salahuddin, in press). A higher score on scales and items indicates more intense fatigue or
greater adverse impact of fatigue. Responses range either from 1-7 or 1-10 depending on the
question; the former were rescaled to range from 1-10 before computing summary scales as
described below. The HRFS has a 7th grade reading level. Subjects whose intensity of fatigue
is low (1 or 2) on all of the first seven HRFS items (i.e., my level of fatigue today, my level of
fatigue on most days, how severe is the fatigue) are told to skip the rest of the instrument
because all of the remaining items are dependent on the subjects being fatigued. Therefore, the
few subjects with virtually no fatigue (n = 15) were given a 1 on all scales, subscales, and
individual items.
Nighttime sleep quality was measured with the Pittsburgh Sleep Quality Index (PSQI) (Buysse,
Reynolds, Monk, Berman, & Kupfer, 1989). The PSQI is a standardized 19-item measure of
sleep quality widely used in the literature because of its strong psychometric properties. The
seven component scores of the PSQI had an overall reliability coefficient of 0.83, indicating a
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high degree of internal consistency. Paired t tests were done to evaluate test-retest reliability
with an outcome of r = 0.85 (p < 0.001) for the global PSQI score (Buysse et al., 1989; Carpenter
& Andrykowski, 1998). In a comparison study evaluating the psychometric properties of the
PSQI across clinical populations, the PSQI global scores were more highly correlated with
sleep problems (r = 0.69-0.77) in comparison to mood and depression (r = 0.22-0.65)
(Carpenter & Andrykowski, 1998). This supports the construct validity of the PSQI as a
measure of sleep problems and not mood disturbance.
The PSQI was developed specifically to be a brief, easily implemented tool that could
distinguish between “good” and “poor” sleepers within a clinical sample. The PSQI asks
questions pertaining to the previous month. The seven component scores range from 0 to 3,
where 0 indicates no difficulty and 3 indicates severe difficulty; these component scores are
then summed for a global score with a range of 0 to 21 points. The seven components of the
PSQI are: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep
disturbances, use of sleeping medications, and daytime dysfunction. It has been proposed that
a PSQI global score of greater than 5 suggests sleep problems (Buysse et al., 1989; Carpenter
& Andrykowski, 1998).
The Epworth Sleepiness Scale (ESS) is a brief questionnaire that asks the respondent to rate
his/her chances of dozing during the daytime in each of eight different situations (Johns,
2000, 2002), which were selected based on their ability to induce dozing. Each of eight items
are ranked from 0 to 3, with a 0 score meaning the respondent would never doze in that situation
and a score of 3 equating to a high chance of dozing. Overall scores can vary from 0-24, with
a score of 10 or less indicating no pathology. Cronbach's alpha is reported at 0.87, indicating
high internal consistency. The reliability of the ESS is similar to the Multiple Sleep Latency
Test (MSLT) (r = 0.81, p < 0.001) (Johns, 2000, 2002).
Recent stressful life events were measured via a methodology developed in a previous 9-year
HIV study showing that cumulative stressors predicted faster HIV disease progression
(Leserman et al., 1999; Leserman et al, 2000; Leserman et al., 2002). Subjects completed a
checklist of possible stressful life events and difficulties experienced during the previous 6
months (list originally modified from the Psychiatric Epidemiology Research Interview
[Dohrenwend, Krasnoff, Askenasy, & Dohrenwend, 1978]). Subjects were then interviewed
concerning the nature and context of each of the endorsed stresses. Interviewers objectively
rated each stress from 0 (no threat) to 4 (severe threat) using a manual of norms and vignettes,
a methodology similar to that developed by Brown and Harris (1978). Norms for each stressful
event were based on the degree of threat that most people would experience given the particular
circumstances (e.g., financial impact, life threat, personal involvement). The objective threat
rating was made independently from the subject's appraisal, in order to reduce the possibility
that worsening disease or fatigue might lead to higher stressful event scores. Two interviewers
were trained by one of the investigators and were allowed to rate stresses independently, after
reliability with the investigator's ratings was achieved (89-90% agreement, Kappa > .83).
Periodic reliability checks and retraining were done to insure that the interviewers maintained
a high level of consistency. All stresses rated above 1 were summed, except that stressors that
were likely to be caused by disease progression (e.g., CD4 count decline, retirement due to
HIV worsening) were removed. Stresses rated as 1 were not counted, as these were typically
positive stresses or daily hassles (e.g., job promotion).
Data Analysis
In bivariable analyses, Pearson correlation coefficients comparing our measures of fatigue and
of sleep quality were calculated. For multiple linear regression models, we standardized both
dependent variables (the fatigue intensity scale and the impact of fatigue on daily functioning
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scale) and independent variables to have mean 0 and standard deviation 1. Thus, regression
coefficients had the interpretation of the change in standard deviation units in the dependent
variable that was associated with a one-standard deviation change in the relevant independent
variable. For each of the two fatigue scales, we fit three models: the first including stress, the
second adding the ESS, and the third adding the PSQI. These models also controlled for
important sociodemographic and clinical covariates as has been previously described (Pence,
Barroso, Leserman, Harmon, & Salahuddin, in press); in short, we entered all
sociodemographic and clinical variables that had a p value < 0.20 in bivariable analyses and
retained only those predictors that remained statistically significantly associated with the
relevant scale at p < 0.05 in the multivariable model. We further forced into the model three
HIV-related clinical variables deemed substantively important: CD4 count, HIV RNA viral
load (log-transformed), and a dichotomous variable indicating whether the participant was on
antiretroviral therapy (ART). We confirmed key model assumptions, including normal
distribution and homoscedasticity of the dependent variables as well as the appropriateness of
linear specifications for continuous independent variables.
Results
The baseline sociodemographic and clinical characteristics of the study sample are described
in Table 1. The majority of subjects were African American (66%), followed by Caucasian
(30%); 4% were other ethnic minorities (i.e., Hispanic, Native American). Sixty-six percent
of the subjects were male, and the median age was 44 years old. The sample was predominantly
made up of people who had lived with HIV infection for a long time, with a median of 10 years
since diagnosis (range 0-25 years). With regard to HIV-related illnesses, 9% of subjects had
experienced a CDC Category B illness, and 17% had experienced a CDC Category C illness.
A large proportion of subjects (82%) were on ART at baseline. The mean CD4 count was 517
cells/mm3 (normal range = 400-1400). The mean HIV viral load was 17,017 copies/mL (mean
log 10 viral load = 2.95); viral loads can range from below the limit of detection (usually 50
copies/mL) to greater than 750,000 copies/mL. The mean score for level of fatigue most days
was 4.9, and the mean score for fatigue severity in the week prior to the first study visit was
5.6 (each on a 1-10 scale).
The mean Global Sleep Quality Score on the PSQI was 9.4 (SD = 4.4) and 80% (103/128) of
participants had scores > 5, indicating substantial sleep problems in this group. The PSQI
subscale scores were as follows: 47% reported that their overall quality of sleep was fairly bad
or very bad; 52% reported trouble getting to sleep; 33% reported 5 or fewer average hours of
sleep per night; 26% reported that the average amount of time in bed spent asleep was less than
65%; 66% reported disturbed sleep; 27% reported using sleep medications three or more times
a week in the past month; and 42% reported sleep-related daytime dysfunction. The mean score
on the ESS was 11 (SD = 5.2) with 55% (70/128) of participants scoring > 10. The correlation
between the PSQI and ESS was low (r = 0.09).
We examined the relationships between the PSQI and ESS scores with two aspects of fatigue:
intensity and impairment of functioning. The PSQI total was significantly correlated with
fatigue intensity (r = 0.46, p < 0.05) and fatigue-related impairment of functioning (r = 0.47,
p < 0.05) (Table 2). Correlations between the ESS and fatigue intensity (r = 0.20, p < 0.05)
and fatigue-related impairment of functioning (r = 0.33, p < 0.05) were of lower magnitude
but still statistically significant.
We previously reported that stressful life events were strong predictors of HIV-related fatigue
intensity and impairment of functioning in this sample (Leserman, Barroso, Pence, Salahuddin,
& Harmon, in press). Here, we investigated whether the relationship between stress and fatigue
was mediated by sleep quality. If participants were experiencing a great deal of stress, did the
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stress impair their sleep, leading to more fatigue? In multiple regression models, the association
between stress and fatigue intensity was not explained by daytime sleepiness and was only
partially explained by nighttime sleep quality (standardized beta shifted from 0.26 to 0.22 with
addition of PSQI to model and remained statistically significant). The association between
stress and fatigue-related impairment of functioning was only marginally explained by daytime
sleepiness (beta shifted from 0.28 to 0.26 with addition of ESS to model) and partially explained
by nighttime sleep quality (beta shifted to 0.20) but remained statistically significant even after
adjustment for both sleep measures.
Discussion
Limitations of the study should be acknowledged. The self-referral method of recruitment in
this study may have introduced selection bias, as individuals experiencing fatigue may have
been more likely to respond to study advertisements than those not fatigued; hence, the
proportion of fatigued participants in this study may be an overestimate of the prevalence of
fatigue among HIV-infected individuals generally. Self-reported measures of fatigue may be
subject to misclassification, which, if nondifferential by other covariates, would tend to bias
estimates of association toward the null.
The HRFS subscales were moderately correlated with poor quality nighttime sleep but showed
only weak correlations with daytime sleepiness. Poorer quality nighttime sleep, as measured
with the PSQI, was moderately associated with greater fatigue intensity and fatigue-related
impairment of functioning. In examining individual components of the PSQI, greater fatigue
was moderately correlated with overall self-reported quality of sleep and sleep-related
dysfunction, i.e., having trouble staying awake during daytime activities, but showed low
correlation with average hours of sleep per night, sleep efficacy (i.e., percent of time in bed
spent sleeping), and use of sleep medications. Of note, the HRFS scales demonstrated a low
correlation with the ESS, a measure of daytime sleepiness, underscoring the conceptual
distinction between “sleepiness” and chronic fatigue. With regard to stress and fatigue, daytime
sleepiness and poor nighttime sleep play some part in mediating the relationship between stress
and fatigue, but stress appears primarily to be related to HIV-related fatigue via some other
mechanism. This intriguing result deserves further scrutiny in future research, as do measures
for improving sleep. We are following this cohort for 3 years, and during that time we hope to
develop a better understanding of the complex relationships between sleep quality, daytime
sleepiness, stressful life events, and HIV-related fatigue. We will be better able to establish the
sequence of events as well – to see how changes in one of these variables may be reflected in
changes in the others later in the study.
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Table 1
Demographic and clinical characteristics of sample (n = 128)
Characteristic N (%) or Median (IQR)








 Heterosexual sex 42 (32.8%)
 IDU 12 (9.4%)
 Other / Multiple / Don't know 24 (18.8%)
Years of schooling (range: 4-20) 12 (12-14)
Monthly income (range: $0-$6,000) $686 ($504-$1,300)
Employed part/full time 42 (32.8%)
Primary caregiver for another 19 (14.8%)
Number of household members 2 (1-3)
Years since HIV diagnosis (range: 0-25) 10 (6-15)
On any antiretroviral therapy 105 (82.0%)
Any HIV-related illness
 CDC Category B 12 (9.4%)
 CDC Category C 22 (17.2%)
Any other chronic illnesses 83 (64.8%)
Current psychotropic medication use 53 (41.4%)
 Antidepressant 50 (39.1%)
 Anxiolytic 19 (14.8%)
Ever used street drugs 98 (76.6%)
Ever used non-marijuana drugs 84 (65.6%)
Currently using street drugs 28 (21.9%)
Ever injected street drugs 26 (20.3%)
Current alcohol problem 12 (9.4%)
Currently in pain 58 (45.3%)
 Pain on 1-10 scale* 7 (5-8)
IQR: Interquartile range (25th-75th percentile). MSM: Men who have sex with men. IDU: Injection drug use
*
Of those reporting any current pain
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Table 3
Multiple regression models of the association between stress, sleep quality, and fatigue
Fatigue intensity











Nighttime sleep quality (PSQI) 0.43*
(0.27, 0.60)











Nighttime sleep quality (PSQI) 0.44*
(0.29, 0.59)
All models additionally adjust for monthly income, years since HIV diagnosis, CD4 count, HIV RNA viral load, and ART status.
ESS=Epworth Sleepiness Scale; PSQI=Pittsburgh Sleep Quality Index.
Results are reported as standardized regression coefficient or beta (95% confidence interval).
*
p < 0.05
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